A number of published studies have put a fluorescent tag onto GLP-1R agonists, including exendin, liraglutide, and semaglutide, and then used the fluorescent labeling to visualize the distribution of the agonist in the brain (see, e.g., Gabery et al., 2020)
Laurindo LF, Barbalho SM, Guiguer EL, da Silva Soares de Souza M, de Souza GA, Fidalgo TM, Arajo AC, de Souza Gonzaga HF, de Bortoli Teixeira D, de Oliveira Silva Ullmann T, Sloan KP, Sloan LA (2022) GLP-1a: Going beyond Traditional Use
Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes
199 Activated Akt promotes the expression and translocation of GLUT4 (Glucose Transporter Type 4) to the cell membrane, increasing cellular glucose uptake
Gentle Patches isnt a traditional weight-loss clinic